Pfizer and Thermo Fisher Scientific Inc. (NYSE: TMO) recently announced that they have entered into a collaboration agreement to help increase local access to next-generation sequencing (NGS)-based testing for lung
The post Thermo Fisher Scientific, Pfizer partner to expand access to next generation sequencing-based testing for cancer patients appeared first on BusinessMirror.
Tuesday 6 June 2023
businessmirror - 12 days ago
Thermo Fisher Scientific, Pfizer partner to expand access to next generation sequencing-based testing for cancer patients
Latest News
Love na babalik-balikan: Skater girl circles McDonald’s Ride-Thru for a heart-fluttering reason.
- businessmirror Vicoap clarifies roadworthiness, verification test required for vehicle registration renewal
- businessmirror Motorbike rider dies after crash during Ironman triathlon European championship race
- businessmirrorHashtags:
Thermo
|Fisher
|Scientific
|Pfizer
|partner
|expand
|access
|generation
|sequencing
|based
|testing
|cancer
|patients
|
AI chips are hot. Here’s what they are, what they’re for and why investors see gold
- businessmirrorASUS shows compelling innovations across product and solutions portfolios along with sustainability achievements at Computex 2023
- businessmirror
One Meralco Foundation takes active role in enhancing disaster response and recovery planning of LGUs
- businessmirror Sources